D.E. Shaw & Co
GMED icon

D.E. Shaw & Co’s Globus Medical GMED Stock Holding History

D.E. Shaw & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
8,300
-20,059
-71% -$1.7M ﹤0.01% 4033
2026
Q1 		$2.44M Sell
28,359
-59,850
-68% -$5.37M ﹤0.01% 2759
2025
Q4 		$7.7M Sell
88,209
-117,964
-57% -$8.95M ﹤0.01% 1975
2025
Q3 		$11.8M Buy
+206,173
New +$11.9M 0.01% 1553
2023
Q4 		– Sell
-546,754
Closed -$27.1M – 4415
2023
Q3 		$27.1M Buy
546,754
+518,756
+1,853% +$29M 0.03% 689
2023
Q2 		$1.67M Buy
27,998
+237
+0.9% +$13.5K ﹤0.01% 2747
2023
Q1 		$1.57M Buy
27,761
+17,035
+159% +$1.09M ﹤0.01% 2856
2022
Q4 		$797K Buy
10,726
+1,785
+20% +$122K ﹤0.01% 3589
2022
Q3 		$533K Buy
+8,941
New +$538K ﹤0.01% 4003
2022
Q1 		– Sell
-4,531
Closed -$327K – 5678
2021
Q4 		$327K Buy
+4,531
New +$329K ﹤0.01% 4640
2020
Q2 		– Sell
-40,028
Closed -$1.7M – 4080
2020
Q1 		$1.7M Buy
+40,028
New +$1.98M ﹤0.01% 2306
2019
Q4 		– Sell
-6,300
Closed -$322K – 4026
2019
Q3 		$322K Buy
+6,300
New +$300K ﹤0.01% 3429
2019
Q1 		– Sell
-4,860
Closed -$210K – 3714
2018
Q4 		$210K Sell
4,860
-1,620
-25% -$80.8K ﹤0.01% 3523
2018
Q3 		$368K Buy
+6,480
New +$341K ﹤0.01% 3271
2016
Q1 		– Sell
-7,343
Closed -$204K – 3549
2015
Q4 		$204K Buy
+7,343
New +$184K ﹤0.01% 3551
2014
Q4 		– Sell
-25,853
Closed -$509K – 4088
2014
Q3 		$509K Sell
25,853
-218,567
-89% -$4.5M ﹤0.01% 3339
2014
Q2 		$5.85M Buy
+244,420
New +$5.9M 0.01% 1498

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

D.E. Shaw & Co's GMED Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Globus Medical (GMED) stake by 71% in Q2 2026, selling an estimated $1.7M and leaving 8,300 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #4033.

D.E. Shaw & Co first reported a position in GMED in Q2 2014 and has held it in 17 quarters since. The position peaked at $27.1M in Q3 2023. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • D.E. Shaw & Co held 8,300 shares of Globus Medical worth $656K as of Q2 2026.
  • D.E. Shaw & Co sold 20,059 Globus Medical shares in Q2 2026, an estimated $1.7M.
  • Globus Medical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4033 holding.
  • D.E. Shaw & Co first reported a position in Globus Medical in Q2 2014 and has held it in 17 quarters since.
  • D.E. Shaw & Co's Globus Medical position peaked at $27.1M in Q3 2023.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.